Jami Rubin , an analyst at Morgan Stanley , said that investors were hoping that Jeffrey B. Kindler , Pfizer 's new chief executive , would be able to cut costs while freeing the company 's scientists to bring drugs to market more quickly .
Jeffrey B. Kindler
Pfizer
/business/person/company
ORGANIZATION
Morgan Stanley
PERSON
Jeffrey B. Kindler
ORGANIZATION
Pfizer